Operationally light
No in-clinic inventory burden. The NAD+ pen is fulfilled through the pharmacy workflow, reducing operational complexity for your practice.
The Medivive NAD+ pen is a 1,000 mg prefilled injector designed for physician-guided care. This NAD pen combines convenient subcutaneous dosing, cGMP 503B manufacturing, and direct-to-patient pharmacy fulfillment.
| Product name | Medivive NAD+ Pen (also called NAD pen) |
|---|---|
| Administration route | Subcutaneous injection (abdomen or thigh) |
| Suggested protocol | 100 mg every 3 days, or 10 units daily with clinician titration |
| Manufacturing | VeV Scientific, FDA-registered cGMP 503B outsourcing facility (San Diego) |
| Dispensing | Chemistry Rx, licensed and PCAB-accredited 503A pharmacy |
| Logistics | Cold-chain shipping direct to patient |
| Storage | Refrigerate 36-46F (2-8C), protect from light, do not freeze |
No in-clinic inventory burden. The NAD+ pen is fulfilled through the pharmacy workflow, reducing operational complexity for your practice.
Prefilled NAD pen delivery supports home administration and repeat adherence without infusion-chair overhead.
Provider economics are simple to model, with recurring refill cadence and direct clinical oversight.
Drug-development origin with cGMP 503B manufacturing and licensed 503A dispensing workflow.
The Medivive NAD+ Pen combines a prefilled injector format, physician-guided prescribing workflow, and cGMP 503B manufacturing with licensed pharmacy fulfillment.
No. Medivive is a prescriber-first platform. The product is physician prescribed and dispensed via pharmacy fulfillment.
Most providers can complete onboarding quickly and begin prescribing after verification and portal setup.
Yes. Prescriptions can include refill workflows designed to support continuity of care and monthly cadence.
Our team can help your practice launch with clear onboarding, workflow setup, and prescribing support.